Chicago Arthritis's overview of GLP-1, CJC-1295, AOD-9604, and related peptides lists nausea, headaches, and fluid retention as possible side effects and stresses that any peptide plan, especially a combined or "stacked" protocol, needs to be built and monitored by a knowledgeable physician (chicagoarthritis.com)
Observe minutely and record any untoward event to the provider
The high costs and resources associated with Phase III trials further highlight their importance in ensuring therapeutic reliability and addressing public health needs effectively
Topical application of Urolithin A slows intrinsic skin aging and protects from UVB-mediated photodamage: Findings from Randomized Clinical Trials D DAmico, AM Fouassier, J Faitg, N Hennighausen, M Brandt, D Konstantopoulos, C Rinsch, A Singh medRxiv 2023.06.16.23291378
Titrate gradually based on clinical response and tolerance
Goytia, Heikkila and Pasquini, 2023